Status:
RECRUITING
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
Lead Sponsor:
Peking University Third Hospital
Conditions:
Lymphadenopathy
Lymphnode Metastasis
Eligibility:
All Genders
18+ years
Brief Summary
Lymph nodes are one of the most important components of the human immune system, and superficial lymph node enlargement lacks specificity. Ultrasound examination has been widely used in the diagnosis...
Detailed Description
The study aim to evaluate the feasibility of SRUS technology in distinguishing between benign and malignant lymph nodes, and compare the differences in blood flow distribution, perfusion index, CEUS p...
Eligibility Criteria
Inclusion
- (1)suggested abnormal lymph nodes indicated by ultrasonography; (2) Patients scheduled for lymph nodes puncture or fine needle aspiration or surgery; (3) Age greater than or equal to 18 years old.
Exclusion
- (1) Pregnant and lactating women; (2)pathological results not indicating benign or malignant lymph nodes; (3) history of chemotherapy or radiotherapy ; (4) History of allergies to eggs, milk, and ultrasound contrast agents; (5) Patients with acute coronary syndrome, severe pulmonary hypertension, or acute respiratory distress syndrome.
Key Trial Info
Start Date :
October 23 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 22 2027
Estimated Enrollment :
779 Patients enrolled
Trial Details
Trial ID
NCT07155954
Start Date
October 23 2024
End Date
October 22 2027
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100049